Head & Neck Cancer, 23-24 September 2022, Singapore
Online application is open until 3 July 2022
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The leading professional organisation for medical oncology
Meet us in Paris to interact with key opinion leaders and learn first-hand about practice challenges and controversies in oncology
Online application is open until 3 July 2022
The most comprehensive series on gastrointestinal cancers – join this highly specialised discussion with top experts
Step out on stage and share your research with a LIVE audience from the Asia-Pacific region and beyond, on 2-4 December in Singapore.
A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Stay up to date with the latest data in HER2+ breast cancer and join this real-time discussion with international experts
From World GI 2022:
TOPAZ-1 exploratory analysis suggests that adding durvalumab to gemcitabine plus cisplatin improves advanced biliary tract cancer outcomes irrespective of the primary tumour site
A focus on the latest research in targeting cancer microbiome
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.